Regeneron Pharmaceuticals, Inc.

Valeo Financial Advisors, LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/4/2026

Shares

1,613

Value ($000)

1,245

Weight

0.0%

2019 Q4 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/4/2026	1,245	0.0%	1,613	12/31/2025
2025 Q3	11/3/2025	1,049	0.0%	1,866	9/30/2025
2025 Q2	9/12/2025	944	0.0%	1,797	6/30/2025
2025 Q1	4/30/2025	753	0.0%	1,188	3/31/2025
2024 Q4	1/30/2025	891	0.0%	1,251	12/31/2024
2024 Q3	10/10/2024	1,626	0.0%	1,547	9/30/2024
2024 Q2	7/10/2024	1,161	0.0%	1,105	6/30/2024
2024 Q1	4/25/2024	811	0.0%	895	3/31/2024
2023 Q4	1/29/2024	562	0.0%	640	12/31/2023
2023 Q3	10/20/2023	509	0.0%	619	9/30/2023
2023 Q2	7/14/2023	371	0.0%	516	6/30/2023
2023 Q1	4/17/2023	505	0.0%	614	3/31/2023
2022 Q4	2/9/2023	329	0.0%	456	12/31/2022
2021 Q4	1/7/2022	246	0.0%	389	12/31/2021
2021 Q3	11/2/2021	232	0.0%	383	9/30/2021
2021 Q2	7/22/2021	203	0.0%	364	6/30/2021
2021 Q1	4/12/2021	170	0.0%	360	3/31/2021
2020 Q4	2/11/2021	251	0.0%	520	12/31/2020
2020 Q3	10/28/2020	291	0.0%	519	9/30/2020
2020 Q2	7/20/2020	279	0.0%	447	6/30/2020
2020 Q1	4/13/2020	218	0.0%	425	3/31/2020
2019 Q4	1/24/2020	154	0.0%	410	12/31/2019